Full-Time

Doctor

Posted on 12/11/2024

Calibrate

Calibrate

201-500 employees

Health-tech startup for sustainable weight loss

Compensation Overview

$200k - $225k/yr

Senior, Expert

Oregon, USA + 10 more

More locations: Iowa, USA | Texas, USA | South Carolina, USA | Tennessee, USA | Virginia, USA | Minnesota, USA | Maine, USA | Massachusetts, USA | North Carolina, USA | Illinois, USA

Candidates must have an active, unrestricted license in IA, IL, MA, ME, MN, NC, OR, SC, TN, TX, or VA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • BC/BE MD - family medicine, internal medicine (with or without subspecialization), or emergency med with primary care experience; other BC/BE physicians with specific obesity medicine experience are also welcome to apply
  • Active, unrestricted license in IA, IL, MA, ME, MN, NC, OR, SC, TN, TX, or VA required
  • Demonstrated excellent written/verbal communication skills and virtual 'bedside' manner
Responsibilities
  • Consistently provide a world-class level of clinical care and patient experience
  • Review patient intake and provide the initial patient interaction, including the discussion of the scientific principles of obesity and the prescription of appropriate weight loss therapy based on Calibrate clinical protocols
  • Review and manage daily tasks, member messages, and lab results during shifts; oversee patient progress; engage with coaches to coordinate care for patients; and review progress in regularly scheduled check-ins
  • Utilize and support a detailed clinical treatment paradigm, developed and updated by the Calibrate team and specialized to support obese patients achieve weight-loss goals
  • Able to commit 40h/wk in a telehealth (remote) setting
  • Supervision and collaboration of Nurse Practitioners
  • Ability to work a variety of shifts including up to 5pm PST
Desired Qualifications
  • A clinical style that will work well with our belief that healthy, long-term, sustainable weight-loss is impossible to achieve without dedicated medical and coaching support
  • Excited to build and deliver a new model for achieving lasting weight health
  • Creative and flexible, but always puts the patient first
  • Excellent at forging successful and respectful relationships with the entire team

Calibrate focuses on sustainable weight loss by improving metabolic health instead of relying on traditional dieting methods. Their program combines gradual habit changes with medication that targets underlying biological factors. This approach has reportedly led to a 15% sustained weight loss in real-world settings, distinguishing Calibrate from other weight loss programs. The subscription-based model is primarily aimed at corporations looking to enhance employee wellness, although individuals can also join. Calibrate offers a money-back guarantee, reflecting confidence in their program's effectiveness. The use of GLP-1 medications helps regulate digestion, reduce inflammation, and improve metabolic function, making the program easier to maintain for users.

Company Size

201-500

Company Stage

Growth Equity (Venture Capital)

Total Funding

$156.6M

Headquarters

New York City, New York

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in personalized medicine boosts demand for Calibrate's tailored weight loss approach.
  • Increasing employer investment in wellness programs expands Calibrate's corporate market.
  • Telehealth models enable Calibrate to reach a broader audience effectively.

What critics are saying

  • Reliance on GLP-1 medications leads to patient complaints and refund issues.
  • Selling to Madryn Asset Management suggests potential financial instability.
  • New CEO may introduce strategic changes disrupting current operations.

What makes Calibrate unique

  • Calibrate combines FDA-approved medication with a holistic curriculum for weight loss.
  • The program offers 1:1 virtual coaching sessions for personalized support.
  • Calibrate focuses on metabolic health rather than traditional dieting methods.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary with opportunity for equity in an early stage, high growth business

Generous paid time off, including an all-company holiday over Thanksgiving week

Calibrate-funded health benefits (medical, dental, vision) - starting at zero cost to you

One Medical membership and Teladoc virtual care

Fertility, gynecology, and wellness services through Kindbody

Therapy on your time with a free year of Talkspace membership

Health advocacy and assistance services through Health Advocate

Commuter benefits, ClassPass memberships, and gym memberships for post-pandemic life

Remote team with a headquarters in NYC

Competitive Paid Parental Leave for parents

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-4%

2 year growth

-6%
Leads on Trees
Sep 21st, 2024
Calibrate Secures $100M in Series B Funding to Revolutionize Weight Treatment

Calibrate secures $100M in series B funding to revolutionize weight treatment.

Hit Consultant
Feb 9th, 2024
Calibrate Appoints Rob Macnaughton As New Ceo

Rob MacNaughhton, CEO at CalibrateWhat You Should Know:– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.MacNaughton Bio/BackgroundMacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”

Endpoints News
Nov 1st, 2023
Weight loss startup Calibrate raises $29M as part of private equity restructuring

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose in popularity with the rise of GLP-1 medications only to struggle to get patients access to those medications — leading to patient complaints and refunds

Endpoints News
Nov 1st, 2023
Weight loss start­up Cal­i­brate rais­es $29M as part of pri­vate eq­ui­ty re­struc­tur­ing

Weight loss start­up Cal­i­brate rais­es $29M as part of pri­vate eq­ui­ty re­struc­tur­ing.

Business Insider
Oct 20th, 2023
Exclusive: Weight-loss startup Calibrate is selling itself to a private equity firm as patient complaints mount

Weight-loss startup Calibrate is selling itself to the private equity firm Madryn Asset Management, Insider has learned.

INACTIVE